
Company Performance - TruBridge reported a quarterly loss of $0.21 per share, significantly below the Zacks Consensus Estimate of $0.52, marking an earnings surprise of -140.38% [1] - The company posted revenues of $83.83 million for the quarter ended September 2024, exceeding the Zacks Consensus Estimate by 1.86% and showing a year-over-year increase from $82.71 million [2] - Over the last four quarters, TruBridge has surpassed consensus revenue estimates four times, but has only exceeded consensus EPS estimates once [2] Stock Movement and Outlook - TruBridge shares have increased by approximately 16.2% since the beginning of the year, while the S&P 500 has gained 24.3% [3] - The future performance of TruBridge's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.52 on revenues of $85.58 million, and for the current fiscal year, it is $0.86 on revenues of $335.87 million [7] Industry Context - The Medical Info Systems industry, to which TruBridge belongs, is currently ranked in the top 22% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact TruBridge's stock performance [5][6]